Je was op zoek naar: newroloġiku (Maltees - Engels)

il-mard newroloĠiku
neurological diseases

mard(a) newroloġiku/a
neurological disease

m’hemmx dejta disponibbli dwar l-iżvillup newroloġiku.
no data are available on neurodevelopment.

il- manteniment jew titjib ta ’ l- istat newroloġiku 4.
maintenance or improvement in neurological status

jekk ikun osservat kompromess newroloġiku, tkun meħtieġa dijanjosi u kura urġenti.
if neurological compromise is noted, urgent diagnosis and treatment is necessary.

mard newroloġiku, bħal enċefalomajelite u s-sindrome ta' guillain barré.
neurological disorders, such as encephalomyelitis and guillain barré syndrome.

neuroped: netwerk ewropew ta’ referenza għal mard newroloġiku rari fit-tfal
neuroped: european network of reference for rare paediatric neurological diseases

mard newroloġiku, bħal enċefalomajelite, newrite u s-sindrome ta’ guillain barré.
neurological disorders, such as encephalomyelitis, neuritis and guillain barré syndrome.

bħalissa għadu mhux magħruf jekk mard newroloġiku bħal dan jgħaddix maż- żmien jew huwiex permanenti.
whether such neurological disorders are transient or permanent is currently unknown.

episodji aktar serji, b’ koma, aċċessjoni, jew indeboliment newroloġiku jistgħu jiġu ttrattati bi ot
more severe episodes, with coma, seizure, or neurological impairment may be treated with in

iż-żmien medjan għall-bidu ta’ avveniment newroloġiku kien ta’ 9 ijiem.
the median time to onset of neurologic event was 9 days.

xi mard newroloġiku li deher iktar tard ġie irrappurtat (ipertonja, aċċessjoni, imġiba mhux normali).
48 some late-onset neurological disorders have been reported (hypertonia, convulsion, abnormal behaviour).

dan jista’ jkun effett sekondarju newroloġiku rari msejjaħ is-sindrome ta’ enċefalopatija posterjuri riversibbli.
this could be a rare neurological side effect named posterior reversible encephalopathy syndrome.

aggravament tal-korea (disturb newroloġiku eżistenti kkaratterizzat minn movimenti spasmodiċi involontarji tal-ġisem)
a worsening of chorea (an existing neurological disorder characterised by involuntary spasmodic movements of the body)

sonovue mhux adattat għall-użu f’pazjenti li qegħdin fuq ventilazzjoni u dawk b’mard newroloġiku mhux stabbli.
sonovue is not suitable for use in ventilated patients, and those with unstable neurological diseases.

mard newroloġiku li deher iktar tard ġie irrappurtat b’mod rari (ipertonja, aċċessjoni, imġiba mhux normali).
late-onset neurological disorders have been reported rarely (hypertonia, convulsion, abnormal behaviour).

jekk għandek disturb newroloġiku (per eżempju korriment fir-ras jew fis-sinsla tad-dahar jew puplesija)
if you have a neurological disorder (for instance head or spinal cord injury or stroke)

il-pazjenti għandhom jiġu sorveljati f’intervalli regolari għal kull sinjal jew sintomu newroloġiku ġdid jew li rkada li jista’ jissuġġerixxi pml.
patients must be monitored at regular intervals for any new or worsening neurological symptoms or signs that may be suggestive of pml.

il-pazjenti għandhom jiġu mmonitorjati f’intervalli regolari għal kwalunkwe sintomu jew sinjal newroloġiku ġdid jew li jkun qed jiggrava, li jista’ jissuġġerixxi pml.
patients must be monitored at regular intervals for any new or worsening neurological symptoms or signs that may be suggestive of pml.

konsegwenzi ta’ theddida għall-ħajja (pressjoni għolja malinna, defiċit newroloġiku, jew kriżi ta’ pressjoni għolja)
life-threatening consequences (malignant hypertension, neurological deficit, or hypertensive crisis)